Express Scripts agreed to overhaul its business model, ensuring patients pay the lowest available price for medications and ...

The FTC's landmark settlement forces Express Scripts PBM to overhaul practices, banning the preference of expensive insulin ...

The Trump administration announced that the company, a pharmacy benefit manager, had agreed to make significant changes to ...

Tables begin to turn on PBM after years of squeezing consumers, employers, and independent pharmaciesAlexandria, Va., Feb. 04 ...

Express Scripts, a pharmacy benefit manager and subsidiary of Cigna (CI), has reached a settlement with the FTC over ...

The agreement announced Wednesday includes sweeping changes to the Cigna PBM’s business practices, including no longer ...

The Federal Trade Commission has reached a landmark settlement with Express Scripts, one of the nation’s largest pharmacy ...

The Federal Trade Commission has announced what it called a “landmark settlement” with Express Scripts over insulin pricing.

The settlement comes after the FTC in September 2024 brought action against three prescription drug benefit managers, including Express Scripts, alleging the companies were artificially inflating the ...

According to Express Scripts, its new pharmacy benefits model, first announced in October 2025, could lower brand name ...

Cigna Corp's Express Scripts settled the U.S. Federal Trade Commission's claims its insulin pricing practices violated ...

The FTC settled a lawsuit against Express Scripts over allegations that the company artificially inflated the price of insulin and impeded access to treatment.